中西医结合治疗对2型早期糖尿病肾病患者血糖、肾功能和生活质量的影响
Effects of Integrative Chinese and Western Medicine on Blood Glucose and Renal Function and Quality of Life in Patients with Type 2 Diabetic Nephropathy
-
摘要: 目的 观察中西医结合治疗对2型早期糖尿病肾病(DN)患者血糖、肾功能和生活质量(QOL)的影响。方法 124例早期DN患者随机分为西药组(n=62)和联合组(n=62),西药组给予传统西药和对症治疗,联合组额外给予自拟中药组方,治疗3个月后评价2组的空腹血糖(FPG)、餐后2 h血糖(2hPG)、血清尿素氮(SUN)、血清肌酐(SCr)、24 h尿白蛋白定量和不良反应,采用简易生活量表(SF-36)评价患者生活质量。结果 2组治疗后FPG、2hPG、BUN、SCr和24 h尿白蛋白定量均明显降低(P<0.05)。治疗后2组BUN、SCr和24 h尿白蛋白定量比较,P<0.05,但FPG、2hPG差异无统计学意义(P>0.05)。西药组和联合组不良反应发生率分别为20.97%和11.29%,有显著性意义(P<0.05)。2组治疗后SF-36量表的8个维度评分均明显增加(P<0.05),但联合组改变更明显,与西药组比较,P<0.05。结论 对于早期DN,在传统西药治疗基础上,联合使用中药,可以明显改善患者的肾功能、降低尿蛋白含量、改善患者的生活质量、降低不良反应。Abstract: OBJECTIVE To investigate the effects of integrative Chinese and western medicine on blood glucose, renal function and quality of life (QOL) in patients with Diabetic nephropathy DN in order to supply strategy for the treatment of early DN. METHODS 124 cases with early DN were randomly divided into western medicine group (n=62) and integrative group (n=62). The former were treated with western medicine and the latter were given Chinese medicine additionally for 3months. The levels of FPG, 2hPG, SUN, SCr and 24 h urine albumin quantitative and adverse reaction were evaluated in both groups and the QOL were measured by SF-36Scale. RESULTS The levels of FPG, 2hPG, SUN, SCr, and 24 h urine albumin quantitative were all significantly decreased after 3-month treatment than those in baseline (P<0.05) of which only SUN, SCr, and 24 h urine albumin were showed significant differences between the two groups(P<0.05). The incidence of adverse reaction was 20 97% in western medicine group, higher than 11.29% in integrative group (P<0.05) The scores in 8 fields of SF-36 Scale were all increased than baseline (P<0.05), but the integrative group changed more (P<0.05). CONCLUSION Integrative Chinese and western medicine can obviously improve the patient's kidney function, reduce urinary protein, improve the patient's quality of life and reduce the adverse reaction in the treatment of early DN.
-
[1] 邵海琳,宋春青,徐东红,等.糖尿病肾病发病的相关因素分析[J].中华流行病学杂志,2013, 34(4):393-395. [2] Shao HL,Song CQ, Xu DH, et al. Analyses on the relative factors regarding diabetic nephropathy[J]. Chin J Epidemiol, 2013,34(4):393-395. [3] 吴雪怡,李航.糖尿病肾病的病理研究及其临床意义[J].中华肾脏病杂志,2012, 28(7):564-569. [4] 〖JP2〗Wu XY, Li H. Pathological study and the clinical significance of diabetic nephropathy[J]. Chin J Nephrol, 2012, 28(7): 564-569.〖JP〗 [5] 李惠秀,曹文富.糖尿病肾病发病机制及治疗进展[J].重庆医学,2013, 42(21):2545-2547, 2568. [6] Li HX, Cao WF. Progress of diabetic nephropathy in its pathogenesis and treatment[J]. Chongqing Med J, 2013,42(21):2545-2547,2568. [7] 韩玲.糖尿病肾病患者肾脏早期损害指标的探讨[J].现代中西医结合杂志,2009,18(4):103-104. [8] Han L. Exploration on the renal injury markerof deabetic nephropathy[J]. Modern J Intergrat Tradit Chin & western Med,2009,18(4):103-104. [9] 中华中医药学会肾病分会.糖尿病肾病诊断,辨证分型及疗效评定(试行方案)[J].上海中医药杂志,2007, 41(7):7. [10] Kidney disease branch of China Association of Chinese Medicine. Diagnosis of diabetic nephropathy, and curative effect evaluation (trial scheme)[J]. Shanghai J Tradit Chin Med, 2007,41(7):7. [11] 贾海骅,赵红霞,赵凯维,等.探讨糖尿病(消渴)中医病因病机[J].中国中医基础医学杂志,2012, 18(1):22, 25. [12] Jia HH, Zhao HX, Zhao KW, et al. Etiology and Pathogenesis of Diabetes[J]. Chin J Basic Med Tradit Chin Med, 2012, 18(1): 22, 25.
点击查看大图
计量
- 文章访问数: 899
- HTML全文浏览量: 8
- PDF下载量: 1063
- 被引次数: 0